Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
54,276,885
-
Share change
-
+1,278,638
-
Total reported value
-
$4,170,062,666
-
Put/Call ratio
-
77%
-
Price per share
-
$76.83
-
Number of holders
-
247
-
Value change
-
+$105,148,741
-
Number of buys
-
108
-
Number of sells
-
126
Institutional Holders of ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) as of Q4 2020
As of 31 Dec 2020,
ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) was held by
247 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,276,885 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, LORD, ABBETT & CO. LLC, ALKEON CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, and ALLIANCEBERNSTEIN L.P..
This page lists
247
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.